Lachman Consultant Services
Keith Lamb is an accomplished professional in the biotechnology and pharmaceutical sectors, currently serving as Vice President of Biologics, Cell and Gene Therapy, and Data Integrity/Data Governance at Lachman Consultant Services. Previously, Keith held the position of Executive Director in the same fields at Lachman Consultant Services and at GlaxoSmithKline as Vice President of Product Quality for Pharma R&D. Keith holds a PhD in Pharmacy from the University of Nottingham and a BSc (Hons) in Microbiology from the University of Surrey.
This person is not in any offices
Lachman Consultant Services
Experience. Excellence. Founded in 1978, Lachman Consultants serves companies in Pharmaceutical, Medical Device/Combination Products, Biologics, and Regulatory Affairs. Each practice offers industry-leading experience and expertise in its area of focus. Lachman Consultants serves emerging-to-enterprise organizations on a worldwide basis, delivering solutions that include FDA-Related Services, Audits & Mock Inspections, Quality Assurance & Controls, Scientific and Technical Assistance, Systems Evaluation, Regulatory Affairs, and Training, which consistently exceed client requirements and expectations. When it comes to compliance and regulatory affairs, Lachman has set the industry standard through senior consultants, efficient engagements, integrated expertise, and loyal clients.